Oxidative stress in pneumococcal meningitis: A future target for adjunctive therapy?

Progress in Neurobiology

Volumn 80, Issue 6, 2006, Pages 269-280

  Klein, Matthias ^a   Koedel, Uwe ^a   Pfister, Hans Walter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Meningitis; N Acetyl l cysteine (NAC); Oxidative stress; Peroxynitrite; Pneumococcal meningitis; Pneumococcus; Streptococcus pneumoniae

Indexed keywords

7 NITROINDAZOLE; ACETYLCYSTEINE; AMINOGUANIDINE; ASCORBIC ACID; BATIMASTAT; BOSENTAN; DEFEROXAMINE; DEXAMETHASONE; DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPID; MANGANESE TETRAKISBENZOIC ACID PORPHYRIN; MELATONIN; METHYLISOTHIOUREA; N NITROARGININE; N TERT BUTYL ALPHA PHENYLNITRONE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; PEROXYNITRITE; PORPHYRIN DERIVATIVE; SUPEROXIDE DISMUTASE; THIOGUANINE DERIVATIVE; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG; URIC ACID;

ADJUVANT THERAPY; ANAPHYLAXIS; ANTIINFLAMMATORY ACTIVITY; BACTERIAL MENINGITIS; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN EDEMA; BRAIN HERNIA; BRAIN ISCHEMIA; BRAIN MITOCHONDRION; BRAIN WATER; CEREBROSPINAL FLUID CYTOLOGY; CHEMOLUMINESCENCE; DNA STRAND BREAKAGE; DRUG EFFICACY; HEARING LOSS; HUMAN; INTRACRANIAL PRESSURE; LEUKOCYTE COUNT; LIPID PEROXIDATION; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEIZURE; STREPTOCOCCUS AGALACTIAE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CHEMOTHERAPY, ADJUVANT; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; MENINGITIS, PNEUMOCOCCAL; MODELS, IMMUNOLOGICAL; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 33846258463     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2006.11.008     Document Type: Review

References (106)

1. Abuja P.M. Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein. FEBS Lett. 446 (1999) 305-308
2. G-methyl-l-arginine protects the guinea pig cochlea from the cytotoxic effects of pneumolysin. Acta Otolaryngol. 115 (1995) 386-391
3. Amaee F.R., Comis S.D., Osborne M.P., Drew S., and Tarlow M.J. Possible involvement of nitric oxide in the sensorineural hearing loss of bacterial meningitis. Acta Otolaryngol. 117 (1997) 329-336
4. Andrew P.J., and Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc. Res. 43 (1999) 521-531
5. Auburtin M., Wolff M., Charpentier J., Varon E., Le T.Y., Girault C., Mohammedi I., Renard B., Mourvillier B., Bruneel F., Ricard J.D., and Timsit J.F. Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit. Care Med. 34 (2006) 2758-2765
6. Auer M., Pfister L.A., Leppert D., Tauber M.G., and Leib S.L. Effects of clinically used antioxidants in experimental pneumococcal meningitis. J. Infect. Dis. 182 (2000) 347-350
7. Ballabh P., Braun A., and Nedergaard M. The blood-brain barrier-an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 16 (2004) 1-13
8. Ballinger S.W., Patterson C., Yan C.N., Doan R., Burow D.L., Young C.G., Yakes F.M., Van H.B., Ballinger C.A., Freeman B.A., and Runge M.S. Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells. Circ. Res. 86 (2000) 960-966
9. Bellac C.L., Coimbra R.S., Christen S., and Leib S.L. Pneumococcal meningitis causes accumulation of neurotoxic kynurenine metabolites in brain regions prone to injury. Neurobiol. Dis. 24 (2006) 395-402
10. Bifrare Y.D., Gianinazzi C., Imboden H., Leib S.L., and Tauber M.G. Bacterial meningitis causes two distinct forms of cellular damage in the hippocampal dentate gyrus in infant rats. Hippocampus 13 (2003) 481-488
11. Boje K.M. Cerebrovascular permeability changes during experimental meningitis in the rat. J. Pharmacol. Exp. Ther. 274 (1995) 1199-1203
12. Boje K.M. Inhibition of nitric oxide synthase partially attenuates alterations in the blood-cerebrospinal fluid barrier during experimental meningitis in the rat. Eur. J. Pharmacol. 272 (1995) 297-300
13. Boje K.M., and Lakhman S.S. Nitric oxide redox species exert differential permeability effects on the blood-brain barrier. J. Pharmacol. Exp. Ther. 293 (2000) 545-550
14. Buster B.L., Weintrob A.C., Townsend G.C., and Scheld W.M. Potential role of nitric oxide in the pathophysiology of experimental bacterial meningitis in rats. Infect. Immun. 63 (1995) 3835-3839
15. Caksen H., Cemek M., Dede S., Dulger H., and Cemek F. Brief clinical study: lipid peroxidation and antioxidant status in children with acute purulent meningitis and encephalitis. Int. J. Neurosci. 114 (2004) 105-111
16. Christen S., Schaper M., Lykkesfeldt J., Siegenthaler C., Bifrare Y.D., Banic S., Leib S.L., and Tauber M.G. Oxidative stress in brain during experimental bacterial meningitis: differential effects of alpha-phenyl-tert-butyl nitrone and N-acetylcysteine treatment. Free Radic. Biol. Med. 31 (2001) 754-762
17. de Gans J., and van de Beek D. Dexamethasone in adults with bacterial meningitis. N. Engl. J. Med. 347 (2002) 1549-1556
18. Dirnagl U., Kodel U., Pfister H.W., Villringer A., Schleinkofer L., and Einhaupl K.M. Detection of brain free oxygen radical generated photons in vivo: preliminary results. Adv. Exp. Med. Biol. 333 (1993) 203-212
19. Dumont R.A., Car B.D., Voitenok N.N., Junker U., Moser B., Zak O., and O'Reilly T. Systemic neutralization of interleukin-8 markedly reduces neutrophilic pleocytosis during experimental lipopolysaccharide-induced meningitis in rabbits. Infect. Immun. 68 (2000) 5756-5763
20. Eichert K., Hamacher J., Wunder M.A., and Wendel A. Intravasal peroxynitrite generation causes dysfunction in the isolated perfused rat lung via endothelin. J. Pharmacol. Exp. Ther. 297 (2001) 128-132
21. Elliott S.J., Lacey D.J., Chilian W.M., and Brzezinska A.K. Peroxynitrite is a contractile agonist of cerebral artery smooth muscle cells. Am. J. Physiol. 275 (1998) H1585-H1591
22. Ge N.N., Brodie S.A., Tinling S.P., and Brodie H.A. The effects of superoxide dismutase in gerbils with bacterial meningitis. Otolaryngol. Head Neck Surg. 131 (2004) 563-572
23. Gerber J., Lotz M., Ebert S., Kiel S., Huether G., Kuhnt U., and Nau R. Melatonin is neuroprotective in experimental Streptococcus pneumoniae meningitis. J. Infect. Dis. 191 (2005) 783-790
24. Greenacre S.A., and Ischiropoulos H. Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic. Res. 34 (2001) 541-581
25. Groves J.T. Peroxynitrite: reactive, invasive and enigmatic. Curr. Opin. Chem. Biol. 3 (1999) 226-235
26. Haberl R.L., Anneser F., Kodel U., and Pfister H.W. Is nitric oxide involved as a mediator of cerebrovascular changes in the early phase of experimental pneumococcal meningitis?. Neurol. Res. 16 (1994) 108-112
27. Haring H., Kampfl A., Grubwieser G., Donnemiller E., Pfausler B., and Schmutzhard E. Cerebral blood flow velocity and perfusion in purulent meningitis: a comparative TCD and 99M-TC-HMPAO-SPECT study. Eur. J. Neurol. 5 (1998) 75-81
28. Hirst R.A., Kadioglu A., O'callaghan C., and Andrew P.W. The role of pneumolysin in pneumococcal pneumonia and meningitis. Clin. Exp. Immunol. 138 (2004) 195-201
29. Huie R.E., and Padmaja S. The reaction of no with superoxide. Free Radic. Res. Commun. 18 (1993) 195-199
30. Ichiyama T., Isumi H., Yoshitomi T., Nishikawa M., Matsubara T., and Furukawa S. NF-kappaB activation in cerebrospinal fluid cells from patients with meningitis. Neurol. Res. 24 (2002) 709-712
31. Irazuzta J.E., Mirkin L.D., and Zingarelli B. Mercaptoethylguanidine attenuates inflammation in bacterial meningitis in rabbits. Life Sci. 67 (2000) 365-372
32. Kastenbauer S., Klein M., Koedel U., and Pfister H.W. Reactive nitrogen species contribute to blood-labyrinth barrier disruption in suppurative labyrinthitis complicating experimental pneumococcal meningitis in the rat. Brain Res. 904 (2001) 208-217
33. Kastenbauer S., Koedel U., Becker B., and Pfister H.W. Pneumococcal meningitis in the rat: evaluation of peroxynitrite scavengers for adjunctive therapy. Eur. J. Pharmacol. 449 (2002) 177-181
34. Kastenbauer S., Koedel U., Becker B.F., and Pfister H.W. Experimental meningitis in the rat: protection by uric acid at human physiological blood concentrations. Eur. J. Pharmacol. 425 (2001) 149-152
35. Kastenbauer S., Koedel U., Becker B.F., and Pfister H.W. Oxidative stress in bacterial meningitis in humans. Neurology 58 (2002) 186-191
36. Kastenbauer S., Koedel U., and Pfister H.W. Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis. J. Infect. Dis. 180 (1999) 1164-1170
37. Kastenbauer S., Koedel U., and Pfister H.W. Oxidative brain damage by peroxynitrite in bacterial meningitis: a target for adjunctive therapy?. Curr. Med. Chem. (2002) 109-127
38. Kastenbauer S., and Pfister H.W. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 126 (2003) 1015-1025
39. Kelly G.S. Clinical applications of N-acetylcysteine. Altern. Med. Rev. 3 (1998) 114-127
40. Kissner R., Nauser T., Bugnon P., Lye P.G., and Koppenol W.H. Formation and properties of peroxynitrite as studied by laser flash photolysis, high-pressure stopped-flow technique, and pulse radiolysis. Chem. Res. Toxicol. 10 (1997) 1285-1292
41. Klein M., Koedel U., Pfister H.W., and Kastenbauer S. Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy. Ann. Neurol. 54 (2003) 451-458
42. Klein M., Koedel U., Pfister H.W., and Kastenbauer S. Morphological correlates of acute and permanent hearing loss during experimental pneumococcal meningitis. Brain Pathol. 13 (2003) 1-10
43. Klein M., Paul R., Angele B., Popp B., Pfister H.W., and Koedel U. Protein expression pattern in experimental pneumococcal meningitis. Microb. Infect. 8 (2006) 974-983
44. Koedel U., Bayerlein I., Paul R., Sporer B., and Pfister H.W. Pharmacologic interference with NF-kappaB activation attenuates central nervous system complications in experimental Pneumococcal meningitis. J. Infect. Dis. 182 (2000) 1437-1445
45. Koedel U., Bernatowicz A., Paul R., Frei K., Fontana A., and Pfister H.W. Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide. Ann. Neurol. 37 (1995) 313-323
46. Koedel U., Gorriz C., Lorenzl S., and Pfister H.W. Increased endothelin levels in cerebrospinal fluid samples from adults with bacterial meningitis. Clin. Infect. Dis. 25 (1997) 329-330
47. Koedel U., Paul R., Winkler F., Kastenbauer S., Huang P.L., and Pfister H.W. Lack of endothelial nitric oxide synthase aggravates murine pneumococcal meningitis. J. Neuropathol. Exp. Neurol. 60 (2001) 1041-1050
48. Koedel U., and Pfister H.W. Protective effect of the antioxidant N-acetyl-l-cysteine in pneumococcal meningitis in the rat. Neurosci. Lett. 225 (1997) 33-36
49. Koedel U., and Pfister H.W. Superoxide production by primary rat cerebral endothelial cells in response to pneumococci. J. Neuroimmunol. 96 (1999) 190-200
50. Koedel U., Scheld W.M., and Pfister H.W. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect. Dis. 2 (2002) 721-736
51. Koedel U., Winkler F., Angele B., Fontana A., and Pfister H.W. Meningitis-associated central nervous system complications are mediated by the activation of poly(ADP-ribose) polymerase. J. Cereb. Blood Flow Metab. 22 (2002) 39-49
52. Koprowski H., Spitsin S.V., and Hooper D.C. Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite. Ann. Neurol. 49 (2001) 139
53. Leib S.L., Kim Y.S., Black S.M., Tureen J.H., and Tauber M.G. Inducible nitric oxide synthase and the effect of aminoguanidine in experimental neonatal meningitis. J. Infect. Dis. 177 (1998) 692-700
54. Leib S.L., Kim Y.S., Chow L.L., Sheldon R.A., and Tauber M.G. Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci. J. Clin. Invest. 98 (1996) 2632-2639
55. Leib S.L., Kim Y.S., Ferriero D.M., and Tauber M.G. Neuroprotective effect of excitatory amino acid antagonist kynurenic acid in experimental bacterial meningitis. J. Infect. Dis. 173 (1996) 166-171
56. Leppert D., Lindberg R.L., Kappos L., and Leib S.L. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res. Brain Res. Rev. 36 (2001) 249-257
57. Loeffler J.M., Ringer R., Hablutzel M., Tauber M.G., and Leib S.L. The free radical scavenger alpha-phenyl-tert-butyl nitrone aggravates hippocampal apoptosis and learning deficits in experimental pneumococcal meningitis. J. Infect. Dis. 183 (2001) 247-252
58. Lorenzl S., Koedel U., Frei K., Bernatowicz A., Fontana A., and Pfister H.W. Protective effect of a 21-aminosteroid during experimental pneumococcal meningitis. J. Infect. Dis. 172 (1995) 113-118
59. Lymar S.V., and Hurst J.K. Radical nature of peroxynitrite reactivity. Chem. Res. Toxicol. 11 (1998) 714-715
60. Marla S.S., Lee J., and Groves J.T. Peroxynitrite rapidly permeates phospholipid membranes. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 14243-14248
61. Matata B.M., and Galinanes M. Peroxynitrite is an essential component of cytokines production mechanism in human monocytes through modulation of nuclear factor-kappaB DNA binding activity. J. Biol. Chem. 277 (2002) 2330-2335
62. Mayhan W.G. Nitric oxide donor-induced increase in permeability of the blood-brain barrier. Brain Res. 866 (2000) 101-108
63. McIntyre P.B., Berkey C.S., King S.M., Schaad U.B., Kilpi T., Kanra G.Y., and Perez C.M. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 278 (1997) 925-931
64. McKnight A.A., Keyes W.G., Hudak M.L., and Jones Jr. M.D. Oxygen free radicals and the cerebral arteriolar response to group B streptococci. Pediatr. Res. 31 (1992) 640-644
65. Meli D.N., Christen S., and Leib S.L. Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway. J. Infect. Dis. 187 (2003) 1411-1415
66. Merchant S.N., and Gopen Q. A human temporal bone study of acute bacterial meningogenic labyrinthitis. Am. J. Otol. 17 (1996) 375-385
67. Mihm M.J., Jing L., and Bauer J.A. Nitrotyrosine causes selective vascular endothelial dysfunction and DNA damage. J. Cardiovasc. Pharmacol. 36 (2000) 182-187
68. Mitchell L., Smith S.H., Braun J.S., Herzog K.H., Weber J.R., and Tuomanen E.I. Dual phases of apoptosis in pneumococcal meningitis. J. Infect. Dis. 190 (2004) 2039-2046
69. Moller K., Qvist T., Tofteng F., Sahl C., Sonderkaer S., Dethloff T., Knudsen G.M., and Larsen F.S. Cerebral blood flow and metabolism during infusion of norepinephrine and propofol in patients with bacterial meningitis. Stroke 35 (2004) 1333-1339
70. Muriel P., and Sandoval G. Hepatic basolateral plasma high-affinity Ca2+-ATPase is inhibited by nitric oxide and peroxynitrite anion. J. Appl. Toxicol. 20 (2000) 435-439
71. Nau R., Soto A., and Bruck W. Apoptosis of neurons in the dentate gyrus in humans suffering from bacterial meningitis. J. Neuropathol. Exp. Neurol. 58 (1999) 265-274
72. Okamoto T., Akaike T., Sawa T., Miyamoto Y., van d.V., and Maeda H. Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J. Biol. Chem. 276 (2001) 29596-29602
73. Ostergaard C., Yieng-Kow R.V., Larsen C.G., Mukaida N., Matsushima K., Benfield T., Frimodt-Moller N., Espersen F., Kharazmi A., and Lundgren J.D. Treatment with a monoclonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally. Clin. Exp. Immunol. 122 (2000) 207-211
74. Park W.S., Chang Y.S., and Lee M. Effect of alpha-phenyl-N-tert-butylnitrone on brain cell membrane function and energy metabolism in experimental Escherichia coli meningitis in the newborn piglet. J. Neurochem. 74 (2000) 763-769
75. Park W.S., Chang Y.S., and Lee M. 7-Nitroindazole, but not aminoguanidine, attenuates the acute inflammatory responses and brain injury during the early phase of Escherichia coli meningitis in the newborn piglet. Biol. Neonate 80 (2001) 53-59
76. Paul R., Koedel U., and Pfister H.W. 7-Nitroindazole inhibits pial arteriolar vasodilation in a rat model of pneumococcal meningitis. J. Cereb. Blood Flow Metab. 17 (1997) 985-991
77. Paul R., Koedel U., Winkler F., Kieseier B.C., Fontana A., Kopf M., Hartung H.P., and Pfister H.W. Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis. Brain 126 (2003) 1873-1882
78. Paul R., Lorenzl S., Koedel U., Sporer B., Vogel U., Frosch M., and Pfister H.W. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann. Neurol. 44 (1998) 592-600
79. Pfister H.W., Borasio G.D., Dirnagl U., Bauer M., and Einhaupl K.M. Cerebrovascular complications of bacterial meningitis in adults. Neurology 42 (1992) 1497-1504
80. Pfister H.W., Kodel U., Dirnagl U., Haberl R.L., Ruckdeschel G., and Einhaupl K.M. Effect of catalase on regional cerebral blood flow and brain edema during the early phase of experimental pneumococcal meningitis. J. Infect. Dis. 166 (1992) 1442-1445
81. Pfister H.W., Koedel U., Dirnagl U., Haberl R.L., Feiden W., and Einhaupl K.M. Superoxide dismutase inhibits brain oedema formation in experimental pneumococcal meningitis. Acta Neurochir. Suppl (Wien.) 51 (1990) 378-380
82. Pfister H.W., Koedel U., Lorenzl S., and Tomasz A. Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats. Stroke 23 (1992) 1798-1804
83. Pfister L.A., Tureen J.H., Shaw S., Christen S., Ferriero D.M., Tauber M.G., and Leib S.L. Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meningitis. Ann. Neurol. 47 (2000) 329-335
84. Quagliarello V., and Scheld W.M. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N. Engl. J. Med. 327 (1992) 864-872
85. Radi R. Peroxynitrite reactions and diffusion in biology. Chem. Res. Toxicol. 11 (1998) 720-721
86. Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 4003-4008
87. Ransohoff R.M., Kivisakk P., and Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 3 (2003) 569-581
88. Rorke L., and Pitts F. Purulent meningitis: the pathologic basis of clinical manifestations. Clin. Pediatr. (Phila) 2 (1963) 64-71
89. Schaefer C.F., Janzen E.G., West M.S., Poyer J.L., and Kosanke S.D. Blood chemistry changes in the rat induced by high doses of nitronyl free radical spin traps. Free Radic. Biol. Med. 21 (1996) 427-436
90. Scheld W.M., Koedel U., Nathan B., and Pfister H.W. Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. J. Infect. Dis. 186 Suppl. 2 (2002) S225-S233
91. Schuchat A., Robinson K., Wenger J.D., Harrison L.H., Farley M., Reingold A.L., Lefkowitz L., and Perkins B.A. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N. Engl. J. Med. 337 (1997) 970-976
92. Sellner J., and Leib S.L. In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation. Neurobiol. Dis. 21 (2006) 647-656
93. Spanaus K.S., Nadal D., Pfister H.W., Seebach J., Widmer U., Frei K., Gloor S., and Fontana A. C-X-C and C-C chemokines are expressed in the cerebrospinal fluid in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. J. Immunol. 158 (1997) 1956-1964
94. Stahel P.F., Nadal D., Pfister H.W., Paradisis P.M., and Barnum S.R. Complement C3 and factor B cerebrospinal fluid concentrations in bacterial and aseptic meningitis. Lancet 349 (1997) 1886-1887
95. Szabo C. DNA strand breakage and activation of poly-ADP ribosyltransferase: a cytotoxic pathway triggered by peroxynitrite. Free Radic. Biol. Med. 21 (1996) 855-869
96. Szabo C. Role of poly(ADP-ribose)synthetase in inflammation. Eur. J. Pharmacol. 350 (1998) 1-19
97. Szabo C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol. Lett. 140-141 (2003) 105-112
98. Szabo C., Cuzzocrea S., Zingarelli B., O'Connor M., and Salzman A.L. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J. Clin. Invest. 100 (1997) 723-735
99. van de Beek D., and de Gans J. Dexamethasone and pneumococcal meningitis. Ann. Intern. Med. 141 (2004) 327
100. van de Beek D., de Gans J., Tunkel A.R., and Wijdicks E.F. Community-acquired bacterial meningitis in adults. N. Engl. J. Med. 354 (2006) 44-53
101. Virag L., Szabo E., Gergely P., and Szabo C. Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol. Lett. 140-141 (2003) 113-124
102. Weisfelt M., van de Beek D., Spanjaard L., Reitsma J.B., and de Gans J. Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case series. Lancet Neurol. 5 (2006) 123-129
103. Whiteman M., Ketsawatsakul U., and Halliwell B. A reassessment of the peroxynitrite scavenging activity of uric acid. Ann. NY Acad. Sci. 962 (2002) 242-259
104. Winkler F., Koedel U., Kastenbauer S., and Pfister H.W. Differential expression of nitric oxide synthases in bacterial meningitis: role of the inducible isoform for blood-brain barrier breakdown. J. Infect. Dis. 183 (2001) 1749-1759
105. Zouki C., Jozsef L., Ouellet S., Paquette Y., and Filep J.G. Peroxynitrite mediates cytokine-induced IL-8 gene expression and production by human leukocytes. J. Leukoc. Biol. 69 (2001) 815-824
106. Zysk G., Bruck W., Gerber J., Bruck Y., Prange H.W., and Nau R. Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J. Neuropathol. Exp. Neurol. 55 (1996) 722-728